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For personality disorder (PD), it is unknown whether additional psychiatric conditions 
increases their risk of self-harm. We thus performed a retrospective cohort study, using data 
from secondary mental healthcare in South London, linked to Hospital Episodes Statistics in 
England to identify self-harm admissions. Adults with diagnosed PD, followed up in a 6-year 
period, were involved (N=7,475). Cox regression was used to model the risk of self-harm 
admissions, with comorbid depression, substance use disorders (SUD), severe mental illness 
(SMI), anorexia nervosa (AN) and bulimia nervosa (BN) as primary exposures, with 
sociodemographics considered as confounders. In multivariable analyses, comorbid SUD 
(adjusted HR=1.66; 95%CI: 1.45, 1.90), depressive disorder (1.25; 1.09, 1.44), AN (1.63; 
1.10, 2.39) and BN (1.65; 1.09, 2.51) were positively associated with increased risks of 
hospitalisation due to self-harm. However, negative association was found for comorbid SMI. 
The findings highlight the importance of assessing and treating comorbid psychiatric 




Personality disorder (PD) is an enduring pattern of inner experience and behaviour that 
deviates markedly from the expectations of the individual's culture, is pervasive and 
inflexible, has an onset in adolescence or early adulthood, is stable over time, and leads to 
distress or impairment (World Health Organization, 1992). PD affects 3-10% of the general 
population (Coid, Yang, Tyrer, Roberts, & Ullrich, 2006; Samuels, 2011; Tyrer et al., 2010); 
the condition is prevalent among those attending primary care (Moran, Jenkins, Tylee, 
Blizard, & Mann, 2000) and up to half of people attending psychiatric outpatient clinics meet 
diagnostic criteria for PD (Beckwith, Moran, & Reilly, 2014; Zimmerman, Chelminski, & 
Young, 2008; Tyrer, Reed, & Crawford, 2015). The public health implications of PD have 
been increasingly appreciated over recent years: as a well characterised risk factor for 
subsequent suicide (Cooper et al., 2005) and associated increased all-cause mortality (Bergen, 
Hawton, Waters, Cooper, & Kapur, 2010), as well as associated with poorer health status 
(Fok et al., 2014; Moran et al., 2016), premature mortality (Bjorkenstam, Bjorkenstam, Holm, 
Gerdin, & Ekselius, 2015), and lower life expectancy (Fok et al., 2012). The economic cost 
of PD (including costs of mental health care and lost employment) in England was estimated 
at £7.9 billion in 2007 and projected to reach £12.29 billion by 2026, comparable to that of 
depression and anxiety disorders, and greater than schizophrenia and bipolar disorders, in 
terms of socioeconomic burdens (McCrone et al., 2008). 
 
Community studies have consistently found strong relationships between PD and other 
mental disorders, such as anxiety and mood disorders (Skodol, Geier, Grant, & Hasin, 2014), 
substance use disorder (Grant et al., 2015), psychosis (Davis, Compton, Wang, Levin, & 
Blanco, 2013), and eating disorders (Samuels, 2011). Overall, Cluster B PDs have the 
strongest relationship with Axis I disorders, particularly substance use disorder and 
 
 
anxiety/mood disorders (Jackson, & Burgess, 2004; Coid et al., 2006; Lenzenweger, & 
Willett, 2007; Trull, Jahng, Tomko, Wood, & Sher, 2010). The presence of PD symptoms 
seems to worsen treatment outcomes of co-occurring Axis I disorders (Goddard, Wingrove, & 
Moran, 2015; Fan, & Hassell, 2008; Moran et al., 2003; Newton-Howes, Tyrer, & Johnson, 
2006). 
 
Self-harm, defined as 'the deliberate, self-inflicted destruction of body tissue without suicidal 
intent and for purposes not socially sanctioned’ (American Psychiatric Association, 2013), is 
common in the general population (Fox et al., 2015) and is a marker of psychological 
distress. A systematic review of 50 studies from 24 countries concluded a 27.5% prevalence 
of PD among people presenting to hospital following self-harm (Hawton, Saunders, 
Topiwala, & Haw, 2013). Moreover, PD is a risk factor for repeated self-harm (Larkin, Di 
Blasi, & Arensman, 2014). For this population of patients therefore, an effective self-harm 
prevention strategy requires improved knowledge and understanding of the specific risk 
factors for self-harm in this vulnerable group. 
 
Among people with BPD, having a history of traumatic experiences, and the presence of 
concurrent major depression have both been linked to an increase in the risk of suicidal 
behaviour (Soloff, Fabio, Kelly, Malone, & Mann, 2005; Zanarini, Laudate, Frankenburg, 
Reich, & Fitzmaurice, 2010). Meanwhile, we know little about the nature of vulnerability 
factors for self-harm among people with the full range of PD. In the current study, we set out 
to address this research gap: in particular to investigate the role of comorbid psychiatric 
disorders (including substance used disorder, SMI, depressive disorder, anorexia nervosa and 





Setting and study design 
A retrospective cohort study was performed using a sample obtained from the South London 
and Maudsley NHS Foundation Trust (SLaM), which provides secondary mental healthcare 
services for 1.36 million residents in a geographic catchment of four south London boroughs: 
Croydon, Lambeth, Lewisham and Southwark. The SLaM Biomedical Research Centre 
(BRC) Case Register collates de-identified copies of full electronic clinical records from 
SLaM, and renders them available for research through the Clinical Record Interactive 
Search (CRIS) platform, established in 2008 (Perera et al., 2016). Hospital Episodes Statistics 
(HES) data contain details of all admissions to National Health Service (NHS) hospitals in 
England. A linkage set up between CRIS and HES datasets was used to detect hospital 
admissions with a primary or secondary diagnosis of self-harm at discharge. 
 
Inclusion criteria 
Our analysed cohort, extracted using CRIS, consisted of individuals meeting the following 
criteria: 1) Having a 10th version International Classification of Diseases (ICD-10) diagnosis 
of a PD (ICD-10 codes F60.0 to F61.0), dated from 1 January 2007 to 31 March 2013; 2) 
Aged 18 years old or above on the start date of the observation window (for those individuals 
whose PD diagnosis was given before the window), or on the date of PD diagnosis (for those 
whose PD diagnosis was given within the observation window). Diagnoses of mental 
disorders were extracted from CRIS, from either a specific field of structured ICD-10 codes, 
or from free-text fields elsewhere in the case record, using a bespoke natural language 
processing algorithm on Generalised Architecture for Text Engineering (GATE) software to 
extract diagnostic statements. All CRIS diagnoses are clinical diagnoses made by clinicians 
and entered into the electronic clinical records of service users as a routine part of their 
 
 
clinical care. The face validity of PD diagnoses on the CRIS system has been previously 
examined against clinical rating of case records, and found to be moderate (kappa = 0.72, p-
value < 0.001) (Fok, Stewart, Hayes, & Moran, 2014; McHugh, 2012). 
 
Comorbid psychiatric disorders 
The following psychiatric disorders (diagnosed at any time before the end of the observation 
window) that are known to a) co-exist frequently with personality disorder, and b) that are of 
particular clinical importance in secondary mental health settings, were selected as the major 
exposures of interest: 
• substance use disorders (ICD 10 codes F10–F19) 
• schizophrenia (F20) 
• schizoaffective disorder (F25) 
• bipolar affective disorder (F31) 
• depressive disorder (F32 or F33) 
• anorexia nervosa (F50.0 or F50.1) and bulimia nervosa (F50.2 or F50.3). 
For the analysis, schizophrenia, schizoaffective disorder and bipolar affective disorder were 
combined as one group - severe mental illness (SMI). 
 
Outcome measure 
The first general hospital admission with self-harm, after the diagnosis of PD and within the 
observation period (1 January 2007 to 31 March 2013), was obtained as the main outcome of 
interest for our analysis. Self-harm was defined in two ways based on the following primary 
or secondary discharge diagnoses associated with HES hospitalisation episodes: a broad 
definition of self-harm (ICD-10 codes X60-84) and a more specific subgroup of self-harm by 
self-poisoning (ICD-10 codes X60-69). 
 
 
Definition of covariates 
Data on age, gender, ethnicity, marital status, residing borough and neighbourhood 
socioeconomic status were retrieved from CRIS. Age in years was defined at the individual’s 
first PD diagnosis date in the observation window or at 1 January 2007, if the PD diagnosis 
preceded the window. Ethnicity was classified into three categories: ‘White’ (including 
‘British’, ‘Any other white background’ and ‘Irish’); ‘Black’ (including ‘African’, ‘Any other 
black background’ and ‘Caribbean’); and ‘Others/Unknown/Mixed’. Marital status was 
classified into four categories: ‘Married’ (including ‘cohabitation’, ‘married’ and 
‘married/civil partnership’); ‘Single’; ‘Divorced/Separated’ (including ‘divorced/ civil 
partnership dissolved’, ‘separated’, ‘widowed’ or ‘widowed/ surviving civil partner’), and 
‘Others’. Same sex couples were not represented in a distinct category; they were classed in 
the same way as other couples, i.e. as ‘single’, ‘cohabitation’, ‘married/civil partnership’, 
‘divorced/civil partnership dissolved’, or ‘widowed/surviving civil partner’, according to 
their marital status. Borough was classified by the subject’s designated primary care trust 
(PCT), and was based on their address of residence: Croydon, Lambeth, Lewisham and 
Southwark, with a fifth ‘other’ group for residents outside the SLaM catchment. 
 
The Index of Multiple Deprivation (IMD) score is an area-level measure of socioeconomic 
status, calculated at the level of lower super output area for residence (LSOA) - a UK address 
grouping construct which contains an average of 1,500 residents. The IMD score is derived 
from a range of area-level domains (including employment, income, education, health, 
barriers to housing and services, crime and the living environment), where each domain is 
given a specific weighting in the calculation of the index. For the analysis, deprivation score 
was assigned based on the individual’s address of residence at the time of PD diagnosis or at 
the beginning of the observation window (for those whose PD diagnosis was made before the 
 
 
window). The score is then transformed into national percentiles (from 1 to 100%), with 
higher scores indicating greater deprivation (lower socioeconomic status) and for our 
analyses, these were further classified by tertiles, with a fourth group for homeless status. 
 
Statistical Analysis 
Because of the cohort study design and the ‘time-to-event’ characteristic in our data for 
current analysis, survival analysis was adopted. Thus, we used Cox proportional hazards 
model to estimate the association of the exposure of interest with self-harm event in the 
follow-up period by hazard ratio (HR), which revealed the relative risk of self-harm in the 
presence of the diagnosis exposure categories listed above. The beginning of the follow-up 
period was defined as the start of the observation window (1 January 2007), if the diagnosis 
was given before the observation window, otherwise the beginning was taken on the date of 
first PD diagnosis occurring within the window. Censoring was defined as the end of the 
observation window (31 March 2013) or the date of death, whichever occurred first. 
Univariable analysis was performed to estimate crude or unadjusted HRs with 95% 
confidence intervals. Multivariable analysis was undertaken using psychiatric comorbidities 
as major exposure of interest to estimate the adjusted hazard ratios (aHRs), controlling for 
age, sex, ethnicity, borough, marital status and deprivation score as confounders. Further 
subgroup analyses by dividing the cohort into Borderline PD and non-Borderline PD 
subgroups on self-harm for outcome with psychiatric comorbidities as the major exposure of 
interest were also performed by univariable analysis and multivariable modelling. All 
statistical analyses were performed using Stata 12.1 (Stata Corporation: College Station, 





CRIS is approved for secondary data analyses of its anonymised health records by the 
Oxfordshire Research Ethics Committee C (latest reference 18/SC/0372) and is stringently 
monitored by a specific patient-led governance structure. 
 
Results 
A total of 7,475 eligible individuals were identified from the CRIS platform as the study 
cohort. Of these, 5,546 subjects had been given PD diagnoses of one or more subtype, and 
1,929 had been diagnosed with no information about subtype. Table 1 shows the breakdown 
of specific personality disorders within the cohort. The most prevalent PD diagnosis was 
emotionally unstable PD (i.e. borderline) PD, which was present in 43% of the sample. Just 
under 1/5 of the sample met criteria for mixed/other personality disorder. Table 2 shows 
descriptive data on sociodemographic characteristics and comorbid psychiatric disorders in 
the sample. The mean age of study subjects was 37 years, over half of them were female and 
the majority (70%) were white and single (69%). The cohort was evenly spread across the 
four boroughs, with 26% from outside the catchment area. The commonest psychiatric 
comorbidity was depression (39%), followed by SMI (32%), substance use disorder (25%), 
anorexia nervosa (1.4%), and bulimia nervosa (1.2%). 
 
In the observation period, there were 956 events of first hospitalisation due to self-harm 
(ICD-10 codes X60-84); 15% of women and 11% of men in the cohort had at least one 
admission due to self-harm. Younger age, female gender, and living outside the SLaM 
catchment area, were associated with an increased risk of first admission due to self-harm. In 
univariable analysis (Table 2, column 3), comorbidity of substance use disorder, anorexia, 
and bulimia were found to be associated with an elevated risk for first self-harm admissions, 
whilst comorbid depression was not a significant correlate and comorbid SMI was associated 
 
 
with lower risk. After adjustment for sociodemographic variables (columns 4-5, Table 2), PD 
subjects with substance use disorder (adjusted HR 1.66; 95% CI: 1.45, 1.91 – representing an 
elevation of relative risk by 66%), depressive disorder (1.25; 1.09, 1.43), anorexia nervosa 
(1.63; 1.10, 2.40) and bulimia nervosa (1.64; 1.08, 2.50) retained significantly increased risks 
of first hospitalisation due to self-harm; whilst comorbid SMI was associated with a 
significantly reduced risk (0.85; 0.74, 0.98). 
 
Considering first admissions specifically due to self-poisoning (ICD 10 codes X60-69) as an 
outcome, similar findings were detected (Table 3). In univariable analysis, comorbidities of 
substance use disorder, anorexia nervosa, and bulimia nervosa were associated with increased 
risk, comorbid depressive disorder was not a significant correlate and comorbid SMI was 
associated with reduced risk. After adjustment for confounders, comorbid substance use 
disorder (adjusted HR 1.71; 95% CI: 1.48, 1.98 - representing an elevation of relative risk by 
71%), depressive disorder (1.27; 1.10, 1.46), anorexia nervosa (1.53; 1.01, 2.30) and bulimia 
nervosa (1.61; 1.04, 2.49) were associated with an elevated risk of hospitalisation due to self-
poisoning, whilst comorbid SMI was associated with reduced risk (0.85; 0.73, 0.99 - 
representing a reduction of relative risk by 15%). 
 
Some differences in demographics and comorbidities were found by comparing persons 
diagnosed with borderline PD with persons diagnosed with other (non-borderline) PD in the 
cohort (Supplementary Table 1). In summary, the BPD group were younger in age (mean 34 
vs. 39 years) and had a greater female preponderance (72% vs. 42%); a larger proportion of 
the BPD group were of white ethnicity (73% vs. 67%), lived outside SLaM catchment area 
(27.3% vs. 24.8%), and fell within the lowest tertile for deprivation (i.e. higher 
socioeconomic status) (33% vs. 30%). In terms of comorbidities, the BPD group had higher 
 
 
prevalence of depression (43% vs. 36%), anorexia nervosa (2.4% vs. 0.6%) and bulimia 
nervosa (2.0% vs. 0.6%), lower prevalence of SMI (28% vs. 36%), and comparable 
prevalence of substance use disorder (26% vs. 24%), compared to the non-BPD group. 
 
In the observation period, there were 547 events of first hospitalisation due to self-harm 
(ICD-10 codes X60-84) amongst the BPD group, and 409 events amongst the non-BPD 
group, yielding an adjusted HR of 1.65 (95% CI: 1.44, 1.89) for the diagnosis of BPD. As to 
the outcome of a narrower definition of self-harm (i.e. ICD-10 codes X60-69), a similar 
adjusted HR of 1.68 (95% CI: 1.45, 1.94) was estimated for BPD. Considering risk of first 
admission due to self-harm (Supplementary Table 2), younger age, and living outside the 
SLaM catchment area, were associated with an increased risk in both the BPD and non-BPD 
group; being female is associated with an increased risk only in the non-BPD group. Being 
homeless, and being of low socioeconomic status, were associated with increased risk in the 
non-BPD group and the BPD group respectively. In univariable analysis (Supplementary 
Table 2, columns 1 and 3), comorbidities of substance use, depression, and bulimia nervosa 
were associated with increased risk in the non-BPD group; in the BPD group substance use 
and anorexia nervosa were associated with increased risk, SMI was associated with reduced 
risk. After adjustment for confounders, non-BPD subjects with comorbid substance use 
disorder (adjusted HR 1.80; 95% CI 1.46, 2.22), depressive disorder (1.54; 1.26, 1.90) and 
bulimia nervosa (2.49; 1.17, 5.32) retained significantly increased risks of first hospitalisation 
due to self-harm. BPD subjects with comorbid substance use disorder (1.48; 1.23, 1.78) and 
anorexia nervosa (1.68; 1.10, 2.56) remained with significantly increased risk; and those with 




In terms of risk of hospitalisation due to self-poisoning (Supplementary Table 3); similar 
findings were detected in the non-BPD group but different in the BPD group. In the 
observation period, there were 498 events of first hospitalisation due to self-harm (ICD-10 
codes X60-84) amongst the BPD group, and 357 events amongst the non-BPD group. In 
univariable analysis, comorbidities of substance use disorder, depression, and bulimia 
nervosa were associated with increased risk in the non-BPD group; in the BPD group only 
substance use disorder was associated with increased risk. After adjustment for confounders, 
non-BPD subjects with comorbid substance use disorder (adjusted HR 1.77; 95% CI 1.41, 
2.22), depression (1.54; 1.23, 1.92), and bulimia nervosa (2.86; 1.34, 6.11) retained 
significantly increased risks of first hospitalisation due to self-poisoning. BPD subjects with 





In this cohort of secondary mental healthcare patients with a diagnosis of personality 
disorder, observed over a 6-year period, 13% had at least one general hospital admission due 
to self-harm (n=956), the vast majority of which were due to self-poisoning (n=855; 89.4%). 
BPD was associated with a higher risk of first hospitalisation due to self-harm, compared to 
non-BPD, no matter which definition of self-harm was adopted. Comorbid substance use 
disorder was independently associated with increased risk of hospitalisation for self-harm, in 
the PD cohort generally, and amongst both BPD and non-BPD subgroups; the association is 
also seen for risk of hospitalisation specifically for self-poisoning. Comorbid depression and 
comorbid bulimia nervosa were independently associated with increased risk of self-harm in 
the PD cohort generally and in the non-BPD subgroup, but not for the BPD subgroup. 
 
 
Comorbid anorexia nervosa was independently associated with increased risk of self-harm in 
the PD cohort generally and in the BPD subgroup but not in the non-BPD subgroup; this 
pattern was also found in self-harm specific to self-poisoning in the whole PD cohort, but not 
for self-poisoning in the BPD subgroup. Comorbid SMI had a protective effect on the risk of 
first self-harm admission, within the PD cohort generally and in the BPD-subgroup, but not 
the non-BPD subgroup; this pattern was also found for self-poisoning in the whole cohort but 
not for self-poisoning in the BPD subgroup. 
 
Comparison to previous research 
To our knowledge, no prior research has focused on comorbid psychiatric disorders as risk 
factors for general hospital admissions for self-harm among individuals with personality 
disorders. Specifically, no other study has investigated comorbid SMI, anorexia nervosa and 
bulimia nervosa as risk factors for self-harm in PD. Our study provides new knowledge of 
comorbid psychiatric disorders as risk factors for self-harm across the whole range of PD. 
Previous studies looking at comorbid psychiatric conditions as predictors of self-harm or 
suicidality in PD have yielded mixed findings. In the Collaborative Longitudinal Study of 
Personality Disorders, which included four types of PD (schizotypal, borderline, avoidant and 
obsessive-compulsive PD), depressive disorder and substance use disorder were not 
predictive of repeated suicide attempts (Boisseau et al., 2013). Studies in BPD samples have 
found depressive disorder to be both predictive of self-harm and not predictive of self-harm; 
whilst substance use disorder appears to be not predictive of self-harm (Zanarini, Laudate, 
Frankenburg, Reich, & Fitzmaurice, 2010; Soloff, & Chiappetta, 2012; Soloff, & Fabio, 
2008; Soloff et al., 2012; Links, Kolla, Guimond, & McMain, 2013). Our finding that both 
comorbid substance use disorder and comorbid depressive disorder increases risk of general 
hospital admission for self-harm is somewhat different to these studies. 
 
 
To the best of our knowledge, no previous study has examined the effect of comorbid 
anorexia nervosa and bulimia nervosa on the risk of self-harm or suicidal behaviour in 
patients with PD. Among people with eating disorders, the presence of comorbid PD, 
especially Cluster BPD, is associated with higher suicidality (Milos, Spindler, Hepp, & 
Schnyder, 2004). The frequencies of both anorexia and bulimia in our study are considerably 
lower than those reported in other comparable studies, meaning that we have likely captured 
a subset of patients with more severe eating disorder and higher likelihood of attracting the 
diagnoses. 
 
A body of literature implicates Axis I comorbidity as an important factor for longitudinal 
outcome in PD. In the Children in the Community Study (Cohen, Crawford, Johnson, & 
Kasen, 2005), co-occurring Axis I with PD in early adolescence increased the odds of PD 
persisting into adulthood; in extended follow-up, over 20 years, co-occurring Axis I and Axis 
II disorders consistently presented the highest risk, often approximating the sum of the axis-
associated risk or even several times the risk of disorders in either axis alone (Crawford et al., 
2008). This risk applies to long-term outcomes in functioning, and persistence of 
psychopathology. The authors posit that, as psychiatric disorders increase in number, they 
may overwhelm a person’s capacity to cope with increased distress, thus leading to worse 
functioning and more persistent disorders over time. In the present study, amongst our cohort 
of individuals with PD, the presence of comorbid psychiatric disorders (excepting comorbid 
SMI) may confer a greater severity and burden of psychopathology and dysfunction, which 
overwhelms the individual’s capacity and resources, thus leading to greater risk of self-harm. 





Also, no prior study has investigated comorbid SMI as a risk factor for self-harm in PD, 
although psychosis has been linked to other negative outcomes in PD, such as risk of violence 
(Moran et al., 2003). Our finding that comorbid SMI is associated with lower risks of self-
harm may have a number of potential explanations, including the possibility of residual 
confounding from protective factors which we failed to adjust for.  These include the 
involvement of crisis teams, which may reduce the risk of suicide in some patients with SMI 
(While et al., 2012). Furthermore, people with SMI comorbid with PD use more secondary 
mental health services compared with the ones diagnosed with SMI or PD alone (Fok et al, 
2014). This increased contact with mental health services (involving support, treatment 
and/or monitoring) may play a role in mitigating self-harm behaviour. Antipsychotic drugs - 
the mainstay of treatment for many patients with SMI – may also reduce the risk of self-harm 
(Hawton et al., 2015), but we were not able to adjust for these variables in analyses. 
 
Strengths and Limitations 
The main strengths of this study were the study design and large clinical cohort. The cohort 
of over 7,000 patients with PD was derived from a secondary mental health setting, which 
covered a full range of inpatient and community-based services, giving sufficient statistical 
power as well as good sociodemographic data for analysis. A range of comorbid psychiatric 
conditions could also be included for investigation, including some that had not been 
previously investigated for self-harm outcomes in people with PD. As for the outcome of 
interest, use of HES linkage data enabled a comprehensive capture of the first hospital 
admissions for self-harm in England. However, there are certain limitations of this study that 
should be noted. We relied on ICD-10 diagnoses as opposed to standardised assessments, but 
the use of routinely collected clinical data allowed us to obtain data on a very large sample 
size, thus optimising the precision of our findings. Moreover, our use of routine clinical 
 
 
diagnoses in a very large population favours generalisability to real-world clinical practice. 
While this study provided a comprehensive sample of people who accessed secondary mental 
healthcare, many people with personality disorders are not seen in secondary mental health 
services and are either managed in a primary care setting, or do not seek or receive any 
treatment at all. Therefore, the results are potentially generalisable only to other secondary 
mental healthcare settings. For the fact of more than a quarter of our study cohort were from 
outside of SLaM service areas, the concern of selection bias may occur when introducing 
these individuals into the analytic sample as their problems may be more intractable and, 
thus, referred to national units in SLaM services for second opinions, advanced assessment or 
treatment. This issue has to be borne in mind for further interpretation of the results. In terms 
of the outcome, given that we only focussed on events which led to hospitalisation, our 
findings cannot be generalised to reflect the risk for all self-harm events among people with 
PD, as many self-harm events either do not come to professional attention, or are not severe 
enough to warrant hospital admission. Lastly, the specific treatment received from mental 
health services, including the provision of crisis support and antipsychotic medication, was 
not included in the analysis, and may represent residual confounding in the study. 
 
Future research could aim to replicate our findings in various settings in the UK and other 
countries with other medical service systems, and to elucidate the potential mechanisms of 
differential outcomes among those with PD and comorbid psychiatric conditions. In 
particular, the finding of a reduced risk associated with SMI comorbidity warrants further 
investigation. Further analysis of the subtypes or clusters of PD with respect to comorbidity 
and self-harm risk would be helpful, as different subtypes of PD are more closely associated 





Among patients with PD, Axis I comorbidities including substance use disorder, depression, 
anorexia nervosa, and bulimia nervosa are independently associated with increased risk of 
first hospital admissions for self-harm, whilst comorbid SMI may be associated with a 
reduction of such a risk. Our findings highlight the importance of assessing and considering 
comorbid psychiatric disorders as a risk factor among people with PD in clinical settings. 
Clinicians and service providers should be aware that comorbidity matters, as it has a bearing 
on treatment outcomes and service use. Early identification of psychiatric comorbidity may 
lead to better treatment and more personalised management of the individual. Subgroups of 
patients with PD and comorbid Axis 1 disorders could also be a target for specific 
interventions to reduce self-harm behaviours. Alertness to the increased vulnerability of those 
with comorbid psychiatric disorders, who have a higher risk of hospitalisation for self-harm, 
allows for the possibility of more effective or pre-emptive engagement on the clinician’s part. 
Effective management of self-harm behaviours at an earlier stage of PD is an urgent and 
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Table 1. Breakdown of specific personality disorder (PD) diagnosis within study cohort (N = 
7,475) 
 
ICD-10 Specific Personality Disorders  Frequency (% of total cohort) 
Paranoid PD 249 (3.3) 
Schizoid PD 108 (1.4) 
Dissocial PD 371 (5.0) 
Emotionally Unstable PD 3219 (43.1) 
Histrionic PD 57 (0.8) 
Anankastic PD 43 (0.6) 
Anxious (Avoidant) PD 90 (1.2) 
Dependent PD 150 (2.0) 




Table 2. Sociodemographic characteristics and psychiatric comorbidities in relation to the first general hospital admissions for intentional self-
harm (ICD-10 codes X60-84) among people with personality disorder by Cox regression (N = 7,475) 
 
Variables 
Mean ± SD / Number 
of individuals (% of 
total cohort) 
Number of first 
admissions for 
intentional self-harm (% 
in row) 
Crude Hazard 
Ratio (95% CI) 
Adjusted Hazard 











































1.15 (0.92, 1.45) 
1.02 (0.77, 1.37) 





















0.44 (0.35, 0.56) 
0.84 (0.68, 1.05) 
0.59 (0.47, 0.75) 





















0.41 (0.32, 0.52) 
0.54 (0.28, 1.04) 
1.13 (0.73, 1.77) 




Deprivation Score in tertiles 
1st tertile (1.44-25.81 percentile) 
2nd tertile (25.82-35.13 percentile) 














0.86 (0.73, 1.01) 
0.88 (0.75, 1.04) 
1.17 (0.92, 1.48) -- -- 
Comorbid psychiatric disorders 


























0.75 (0.65, 0.86) 
 
Reference 














1.06 (0.94, 1.21) 
Reference 











2.42 (1.65, 3.55) 
Reference 












2.25 (1.49, 3.40) 
Reference 
1.64 (1.08, 2.50) 0.02 
*Adjusted for age, sex, ethnicity, borough, marital status and deprivation score, separately for comorbid psychiatric disorders 
^ Severe mental illness, including schizophrenia, bipolar disorder, and schizoaffective disorder 
 
 
Table 3. Sociodemographic characteristics and psychiatric comorbidities in relation to the first general hospital admissions due to self-harm by 
poisoning (ICD 10 codes X60-69) among people with personality disorder by Cox regression (N=7,475) 
Variables 
Mean ± SD / 
Numbers of 
individuals (% of 
total cohort) 
Number of first 
admissions for 
intentional self-harm by 
poisoning (% in row) 
Crude Hazard 
Ratio (95% CI) 
Adjusted Hazard 








































1.09 (0.86, 1.38) 
0.97 (0.72, 1.32) 






















0.41 (0.32, 0.54) 
0.90 (0.72, 1.12) 
0.58 (0.45, 0.74) 






















0.43 (0.33, 0.55) 
0.54 (0.27, 1.08) 
1.08 (0.67, 1.74) 




Deprivation Score in tertiles 
1st (1.44-25.81 percentile) 
2nd (25.82-35.13 percentile) 














0.83 (0.70, 0.99) 
0.88 (0.74, 1.04) 
1.18 (0.92, 1.52) 
-- -- 
Comorbid psychiatric disorders 






























0.74 (0.64, 0.86) 
 
Reference 















1.08 (0.95, 1.24) 
Reference 












2.37 (1.58, 3.56) 
Reference 












2.28 (1.48, 3.52) 
Reference 
1.60 (1.04, 2.49) 0.03 
*Adjusted for age, sex, ethnicity, borough, marital status and deprivation score, separately for comorbid psychiatric disorders 
^ Severe mental illness, including schizophrenia, bipolar disorder, and schizoaffective disorder 
 
 
Supplementary Table 1. Comparisons of demographics and comorbidities between groups of borderline PD and non-borderline PD 
Variables 
Mean ± SD / Numbers of individuals (% in columns) 
^p-value 
Non-Borderline Personality Disorder 
(n=4,256) 
Borderline Personality Disorder 
(n=3,219) 




































































Deprivation Score in tertiles 
1st (1.44-25.81 percentile) 
2nd (25.82-35.13 percentile) 


















Comorbid psychiatric disorders 




















































^ Independent t-tests for continuous variables and Chi-square tests for categorical variables 
& Severe mental illness, including schizophrenia, bipolar disorder, and schizoaffective disorder 
 
 
Supplementary Table 2. Effects of sociodemographic characteristics and psychiatric comorbidities in relation to the first general hospital admissions 
for intentional self-harm (ICD-10 codes X60-84) among people with personality disorder by Cox regression, stratified by diagnosis with borderline 
PD and with other (non-borderline) PD (N=7,475) 
Variables 
Non-Borderline Personality Disorder (n=4,256) Borderline Personality Disorder (n=3,219) 
Crude Hazard Ratio 
(95% CI) 
Adjusted Hazard 
Ratio* (95% CI) 
Crude Hazard Ratio 
(95% CI) 
Adjusted Hazard 
Ratio* (95% CI) 






















1.11 (0.78, 1.56) 
1.01 (0.65, 1.56) 




1.18 (0.87, 1.61) 
1.07 (0.73, 1.58) 










0.52 (0.36, 0.74) 
1.04 (0.76, 1.45) 
0.78 (0.56, 1.08) 




0.42 (0.30, 0.58) 
0.73 (0.55, 0.98) 
0.51 (0.36, 0.71) 










0.38 (0.26, 0.54) 
0.50 (0.19, 1.35) 
0.86 (0.41, 1.82) 




0.51 (0.37, 0.72) 
0.63 (0.26, 1.52) 
1.47 (0.85, 2.55) 





Deprivation Score in tertiles 
1st (1.44-25.81 percentile) 
2nd (25.82-35.13 percentile) 




1.02 (0.79, 1.32) 
1.17 (0.91, 1.51) 




0.81 (0.66, 1.00) 
0.74 (0.60, 0.91) 
1.23 (0.88, 1.73) 
-- 
Comorbid psychiatric disorders 
























0.82 (0.67, 1.01) 
 
Reference 
0.97 (0.78, 1.19) 
 
Reference 
0.76 (0.63, 0.93) 
 
Reference 






1.37 (1.13, 1.67) 
Reference 
1.54 (1.26, 1.90) 
 
Reference 
0.80 (0.67, 0.95) 
 
Reference 






1.74 (0.65, 4.65) 
 
Reference 
1.10 (0.41, 2.98) 
 
Reference 
2.02 (1.33, 3.07) 
 
Reference 






3.27 (1.54, 6.90) 
 
Reference 
2.49 (1.17, 5.32) 
 
Reference 
1.55 (0.94, 2.55) 
 
Reference 
1.43 (0.86, 2.36) 
*Adjusted for age, sex, ethnicity, borough, marital status and deprivation score, separately for comorbid psychiatric disorders 
^ Severe mental illness, including schizophrenia, bipolar disorder, and schizoaffective disorder 
 
 
Supplementary Table 3. Effects of sociodemographic characteristics and psychiatric comorbidities in relation to the first general hospital admissions 
for to self-harm by poisoning (ICD 10 codes X60-69) among people with personality disorder by Cox regression, stratified by if ever being diagnosed 
borderline personality disorder (N=7,475) 
Variables 
Non-Borderline Personality Disorder (n=4,256) Borderline Personality Disorder (n=3,219) 
Crude Hazard Ratio 
(95% CI) 
Adjusted Hazard 
Ratio* (95% CI) 
Crude Hazard Ratio 
(95% CI) 
Adjusted Hazard 
Ratio* (95% CI) 






















1.03 (0.72, 1.49) 
0.98 (0.62, 1.56) 




1.12 (0.82, 1.53) 
0.99 (0.66, 1.48) 










0.50 (0.33, 0.74) 
1.11 (0.78, 1.57) 
0.77 (0.54, 1.11) 




0.39 (0.28, 0.56) 
0.79 (0.59, 1.07) 
0.51 (0.36, 0.73) 










0.38 (0.26, 0.56) 
0.44 (0.14, 1.36) 
0.84 (0.38, 1.90) 




0.56 (0.40, 0.78) 
0.70 (0.29, 1.69) 
1.37 (0.75, 2.49) 





Deprivation Score in tertiles 
1st (1.44-25.81 percentile) 
2nd (25.82-35.13 percentile) 




0.94 (0.71, 1.25) 
1.21 (0.92, 1.58) 




0.82 (0.66, 1.01) 
0.72 (0.58, 0.90) 
1.13 (0.78, 1.63) 
-- 
Comorbid psychiatric disorders 
























0.77 (0.62, 0.97) 
 
Reference 
0.92 (0.73, 1.16) 
 
Reference 
0.80 (0.65, 0.98) 
 
Reference 






1.37 (1.11, 1.68) 
 
Reference 
1.54 (1.23, 1.92) 
 
Reference 
0.83 (0.70, 0.99) 
 
Reference 






2.01 (0.75, 5.38) 
Reference 
1.23 (0.45, 3.31) 
 
Reference 
1.88 (1.20, 2.95) 
 
Reference 






3.80 (1.80, 9.04) 
 
Reference 
2.86 (1.34, 6.11) 
 
Reference 
1.47 (0.86, 2.50) 
 
Reference 
1.29 (0.76, 2.22) 
*Adjusted for age, sex, ethnicity, borough, marital status and deprivation score, separately for comorbid psychiatric disorders 
^ Severe mental illness, including schizophrenia, bipolar disorder, and schizoaffective disorder 
 
